Report : Europe Fish Protein Isolates Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Form (Powder and Liquid) and Application (Food and Beverages, Pharmaceuticals and Nutraceuticals, Personal Care, and Animal Nutrition)
At 3.7% CAGR, the Europe Fish Protein Isolates Market is speculated to be worth US$ 384.15 million by 2028, says Business Market Insights
According to the Insight Partners’ research, the Europe fish protein isolates market was valued at US$ 308.19 million in 2022 and is expected to reach US$ 384.15 million by 2028, registering an annual growth rate of 3.7% from 2022 to 2028. Rising application of fish protein isolates in various end-use industries and surge in demand for protein-rich food products are the critical factors attributed to the Europe fish protein isolates market expansion.
Fish protein isolate is a versatile product used in various end-use industries such as pharmaceutical & nutraceuticals, personal care, dietary supplements, and animal nutrition. Fish protein isolates are used in animal feeds because they are high in protein concentration and are also a good source of phosphorus, calcium, and other minerals. Fish protein isolates are also widely used in aquaculture feeds because of its high protein content and excellent amino acid balance for aquatic animals. Further, due to the antioxidant, antimicrobial, and antiaging properties of fish protein isolates, it is highly used in the pharmaceutical & nutraceuticals industry. Pharmaceuticals and nutraceuticals that are rich in fish protein can help prevent acute and chronic diseases, delay the aging process, increase life expectancy, and support the basic structure and functions of the body. The personal care industry is flourishing as consumers are becoming more conscious of their physical appearance. Fish protein isolates are used to manufacture various personal care products, such as skin care creams and moisturizers. Fish protein isolates contain microelements that improve skin structure and maintain skin elasticity. Fish protein isolates are utilized for developing cosmeceutical products due to their skin repair and tissue regeneration abilities. Fish protein isolate's help to improve the human digestion cycle, this factor makes it ideal for dietary supplements and sports nutrition. Hence, increased demand for dietary supplements among sportspersons, athletes, and fitness enthusiasts, catalyze the use of fish protein isolates in sports nutrition. Furthermore, the presence of several essential micronutrients in fish protein isolates, make it a good source to overcome malnutrition.
On the contrary, rising vegan population hurdles the growth of Europe fish protein isolates market.
Based on form, the Europe fish protein isolates market is bifurcated into powder and liquid. The powder segment held 91.8% share of the Europe fish protein isolates market in 2022, amassing US$ 283.02 million. It is projected to garner US$ 353.07 million by 2028 to expand at 3.8% CAGR during 2022–2028.
Based on application, the Europe fish protein isolates market is segmented into food and beverages, pharmaceuticals and nutraceuticals, personal care, and animal nutrition. The pharmaceuticals and nutraceuticals segment held 38.5% share of the Europe fish protein isolates market in 2022, amassing US$ 118.59 million. It is projected to garner US$ 141.58 million by 2028 to expand at 3.0% CAGR during 2022–2028.
Based on country, the Europe fish protein isolates market has been categorized into Germany ,the UK, France, Italy, Russia, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 43.5% share of the Europe fish protein isolates market in 2022. It was assessed at US$ 134.17 million in 2022 and is likely to hit US$ 161.31 million by 2028, exhibiting a CAGR of 3.1% during the forecast period.
Key players profiles in the Europe fish protein isolates market report are Advance International, Inc; Bio-marine Ingredients Ireland Ltd; Biomega Group AS; Copalis Industry SAS; Hofseth BioCare ASA; PeterLabs Holdings Sdn Bhd; and Sopropeche SA, among others.
- May-2021, Biomega Group AS), a leading biosciences company producing high-quality marine ingredients, has announced the expansion of its biorefining footprint by investing in a new greenfield site in Hirtshals, Denmark.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org